AU3774500A - Nucleic acids including open reading frames encoding polypeptides; "orfx" - Google Patents

Nucleic acids including open reading frames encoding polypeptides; "orfx"

Info

Publication number
AU3774500A
AU3774500A AU37745/00A AU3774500A AU3774500A AU 3774500 A AU3774500 A AU 3774500A AU 37745/00 A AU37745/00 A AU 37745/00A AU 3774500 A AU3774500 A AU 3774500A AU 3774500 A AU3774500 A AU 3774500A
Authority
AU
Australia
Prior art keywords
orfx
nucleic acids
open reading
reading frames
acids including
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37745/00A
Inventor
Martin Leach
Richard A. Shimkets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU3774500A publication Critical patent/AU3774500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
AU37745/00A 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; "orfx" Abandoned AU3774500A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US12760799P 1999-03-31 1999-03-31
US60127607 1999-03-31
US12763699P 1999-04-02 1999-04-02
US60127636 1999-04-02
US12772899P 1999-04-05 1999-04-05
US60127728 1999-04-05
US54076300A 2000-03-30 2000-03-30
US09540763 2000-03-30
PCT/US2000/008621 WO2000058473A2 (en) 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Publications (1)

Publication Number Publication Date
AU3774500A true AU3774500A (en) 2000-10-16

Family

ID=27494693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37745/00A Abandoned AU3774500A (en) 1999-03-31 2000-03-31 Nucleic acids including open reading frames encoding polypeptides; "orfx"

Country Status (5)

Country Link
EP (1) EP1165784A2 (en)
JP (1) JP2004507202A (en)
AU (1) AU3774500A (en)
CA (1) CA2383592A1 (en)
WO (1) WO2000058473A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001262734B2 (en) * 2000-06-14 2004-09-30 Sankyo Company, Limited Ceramide kinase and DNA encoding the same
AU783485B2 (en) * 1999-11-10 2005-11-03 Lexicon Pharmaceuticals, Inc. Human atpase proteins and polynucleotides encoding the same
AU784349B2 (en) * 2000-01-12 2006-03-16 Yale University Nogo receptor-mediated blockade of axonal growth
AU2001249421B2 (en) * 2000-03-24 2006-09-07 Genetics Institute, Llc A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor

Families Citing this family (256)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040466A2 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6372473B1 (en) * 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
US6528640B1 (en) * 1997-11-05 2003-03-04 Ribozyme Pharmaceuticals, Incorporated Synthetic ribonucleic acids with RNAse activity
US6482932B1 (en) * 1997-11-05 2002-11-19 Ribozyme Pharmaceuticals, Incorporated Nucleoside triphosphates and their incorporation into oligonucleotides
US6617438B1 (en) * 1997-11-05 2003-09-09 Sirna Therapeutics, Inc. Oligoribonucleotides with enzymatic activity
US6300096B1 (en) 1998-01-15 2001-10-09 Whitehead Institute For Biomedical Research Polynucleotides encoding fatty acid transport proteins
US7033772B1 (en) 1998-01-15 2006-04-25 Millennium Pharmaceuticals, Inc. Methods of identifying inhibitors of fatty acid transport proteins (FATP)
US6365365B1 (en) 1998-03-20 2002-04-02 The Regents Of The University Of California Method of determining whether an agent modulates glycosyl sulfotransferase-3
US6265192B1 (en) 1998-03-20 2001-07-24 The Regents Of The University Of California Glycosly sulfortransferase-3
US20030134327A1 (en) 1998-05-15 2003-07-17 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001062926A2 (en) * 2000-02-25 2001-08-30 Millennium Pharmaceuticals, Inc. 44576, a novel g-protein coupled receptor and uses therefor
EP1593687A3 (en) * 1998-06-10 2006-10-18 Bayer Corporation Human genes differentially expressed in colon cancer
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7258973B2 (en) * 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
US20030096391A1 (en) * 2000-12-22 2003-05-22 Millennium Pharmaceuticals, Inc. 17903, a novel human aminopeptidase and uses therefor
US6730491B2 (en) 2000-02-29 2004-05-04 Millennium Pharmaceuticals, Inc. 2504, 15977, and 14760, novel protein kinase family members and uses therefor
JP4315301B2 (en) * 1998-10-30 2009-08-19 独立行政法人科学技術振興機構 Human H37 protein and cDNA encoding this protein
US6743602B1 (en) 1999-07-26 2004-06-01 Chiron Corporation Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
US7867731B2 (en) 1998-11-04 2011-01-11 Novartis Vaccines And Diagnostics, Inc. HX2004-6 polypeptide expressed in cancerous cells
EP1141269A4 (en) * 1998-12-30 2003-03-26 Millennium Pharm Inc Secreted proteins and uses thereof
EP1277833B1 (en) * 1999-02-12 2006-02-22 Genentech, Inc. Gene that is amplified in tumours, and related materials and methods
CA2479494C (en) * 1999-03-08 2010-02-02 Genentech, Inc. Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
DE60039677D1 (en) * 1999-03-19 2008-09-11 Aventis Pharma Inc AKT-3 NUCLEIC ACID, POLYPEPTIDES, AND ITS USE
ATE449108T1 (en) * 1999-03-23 2009-12-15 Genentech Inc SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACID CODING THEREFOR
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1180151A2 (en) * 1999-05-28 2002-02-20 Sugen, Inc. Protein kinases
AU5309500A (en) * 1999-06-07 2000-12-28 Lexicon Genetics Incorporated Novel human genes and proteins encoded thereby
AU5744200A (en) * 1999-06-17 2001-01-09 Incyte Genomics, Inc. Human transport proteins
DE19928021A1 (en) * 1999-06-18 2000-12-21 Basf Ag New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders
AU5799500A (en) * 1999-06-29 2001-01-22 Mcgill University Human alpha 1,2-mannosidase
JP2003526337A (en) * 1999-07-23 2003-09-09 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 29 human secreted proteins
WO2001007614A1 (en) * 1999-07-26 2001-02-01 Chiron Corporation Polynucleotides differentially expressed in adenocarcinomas, polypeptides encoded thereby, and methods of use thereof
DE19936563A1 (en) * 1999-08-04 2001-02-08 Boehringer Ingelheim Int Tumor Associated Antigen
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
US6818750B2 (en) * 1999-09-01 2004-11-16 The Burnham Institute Card proteins involved in cell death regulation
WO2001016336A1 (en) * 1999-09-02 2001-03-08 Lexicon Genetics Incorporated Human calcium dependent proteases and polynucleotides encoding the same
EP1127118A1 (en) * 1999-09-02 2001-08-29 Smithkline Beecham Plc Human gs protein regulator gene
US7329529B2 (en) 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
US20020045212A1 (en) * 2000-02-29 2002-04-18 Glucksmann Maria Alexandra Novel human GTPase activator proteins
US6329171B1 (en) * 1999-09-30 2001-12-11 Millennium Pharmaceuticals, Inc. 23484, A novel human ubiquitin protease
WO2001018037A2 (en) * 1999-09-07 2001-03-15 University Health Network A p53-induced protein with a death domain that can promote apoptosis
JP2003527092A (en) * 1999-09-15 2003-09-16 インサイト・ゲノミックス・インコーポレイテッド Proteins involved in cell differentiation
WO2001019850A2 (en) * 1999-09-16 2001-03-22 Mcgill University Nrage nucleic acids and polypeptides and uses thereof
US7029895B2 (en) 1999-09-27 2006-04-18 Millennium Pharmaceuticals, Inc. 27411, a novel human PGP synthase
US6451994B1 (en) 1999-09-27 2002-09-17 Millennium Pharmaceuticals, Inc. 23413, a novel human ubiquitin protease
GB9924060D0 (en) * 1999-10-11 1999-12-15 Chiron Spa VIP54 protein
US6420155B1 (en) * 1999-10-14 2002-07-16 Curagen Corporation Aortic carboxypeptidase-like protein and nucleic acids encoding same
US20020081625A1 (en) * 1999-10-14 2002-06-27 John Ford Member of the immunoglobulin superfamily and uses thereof
EP1222264A1 (en) * 1999-10-19 2002-07-17 The Wellcome Trust Limited as Trustee to the Wellcome Trust Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof
US20020081679A1 (en) * 1999-10-22 2002-06-27 Millennium Pharmaceuticals, Inc. NARC8 programmed cell-death-associated molecules and uses thereof
WO2001031034A1 (en) * 1999-10-25 2001-05-03 Millennium Pharmaceuticals, Inc. 27875 a human adam-ts homolog
CA2389305A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins
JP2003519472A (en) 1999-11-15 2003-06-24 フアルマシア・イタリア・エツセ・ピー・アー PAK5, a member of the P21-activated kinase (PAK) protein family, nucleic acids and methods related thereto
EP1244793A2 (en) * 1999-11-17 2002-10-02 Curagen Corporation Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
US20030109428A1 (en) 1999-12-01 2003-06-12 John Bertin Novel molecules of the card-related protein family and uses thereof
WO2001040468A2 (en) * 1999-12-01 2001-06-07 Millennium Pharmaceuticals, Inc. Molecules of the card-related protein family and uses thereof
AU2084601A (en) * 1999-12-10 2001-06-18 Biogen, Inc. Novel polypeptides and polynucleotides encoding same
US7115558B2 (en) * 1999-12-16 2006-10-03 Cytochroma Inc. P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
US20030165897A1 (en) * 1999-12-21 2003-09-04 Burke Richard E. Dispatched polypeptides
WO2001046397A2 (en) * 1999-12-23 2001-06-28 Incyte Genomics, Inc. Human kinases
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
WO2001057203A1 (en) * 2000-02-01 2001-08-09 Taisho Pharmaceutical Co.,Ltd. NOVEL GENE tig104α AND PROTEIN TIG104α ENCODED THEREBY
WO2001057060A1 (en) * 2000-02-01 2001-08-09 Human Genome Sciences, Inc. Bcl-2-like polynucleotides, polypeptides, and antibodies
US7335749B2 (en) 2000-02-09 2008-02-26 The United States Of America As Represented By The Department Of Health And Human Services Tumor suppressor gene, p47Ing3
US7078205B2 (en) 2000-02-17 2006-07-18 Millennium Pharmaceuticals, Inc. Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
DE10007468A1 (en) * 2000-02-18 2001-08-23 Basf Lynx Bioscience Ag New central nervous protein that modulates K · + · currents
SE0100472L (en) * 2000-02-18 2001-08-19 Hoffmann La Roche New metalloproteases having thrombospondome domains and nucleic acid compositions encoding these
GB0004196D0 (en) * 2000-02-19 2000-04-12 Smithkline Beecham Plc Novel compounds
US20020042098A1 (en) * 2000-02-29 2002-04-11 Rachel Meyers 32253 transferase family members and uses therefor
US20040033509A1 (en) 2000-07-18 2004-02-19 Millennium Pharmaceuticals, Inc. Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor
US6864078B2 (en) 2000-02-29 2005-03-08 Millennium Pharmaceuticals, Inc. 14790, novel protein kinase molecule and uses therefor
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001245354A1 (en) * 2000-03-02 2001-09-12 Human Genome Sciences, Inc. Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
AU2001236039A1 (en) * 2000-03-02 2001-09-12 Chugai Seiyaku Kabushiki Kaisha Dna encoding squalene epoxidase promoter
US7301016B2 (en) 2000-03-07 2007-11-27 Millennium Pharmaceuticals, Inc. Human transferase family members and uses thereof
WO2001090322A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 32244, a novel human amp-binding enzyme and uses thereof
US20020055159A1 (en) * 2000-06-15 2002-05-09 Meyers Rachel A. 23680,a novel human aminotransferase and uses therefor
AU2001243449A1 (en) * 2000-03-07 2001-09-17 Millenium Pharmaceuticals, Inc. 22105, a novel human thioredoxin family member and uses thereof
JP2003526369A (en) * 2000-03-10 2003-09-09 キュラジェン コーポレイション Novel polynucleotides and nucleic acids encoding the same
CA2403809A1 (en) * 2000-03-22 2001-09-27 Curagen Corporation Angiogenesis - associated proteins, and nucleic acids encoding the same
AU2001252957A1 (en) * 2000-03-24 2001-10-08 Millennium Pharmaceuticals, Inc. Human methyl transferase family member, 25552, and uses thereof
JP2001335598A (en) * 2000-03-24 2001-12-04 Takeda Chem Ind Ltd New protein, method for producing the same and use thereof
US7166701B2 (en) * 2000-03-24 2007-01-23 Merck Patent Gmbh Human survivin interacting protein 1 (SIP-1)
AU2001247570A1 (en) * 2000-03-24 2001-10-08 Millennium Pharmaceuticals, Inc. 32451, a novel human ubiquitin conjugating enzyme-like molecule and uses thereof
EP1138768A3 (en) * 2000-03-27 2002-08-07 Leadd B.V. Apoptin-associating protein AAP-5
EP1138765A1 (en) * 2000-03-27 2001-10-04 Leadd B.V. Apoptin-associating proteins AAP-5 and AAP-6
FR2806739B1 (en) 2000-03-27 2005-02-18 Fond Jean Dausset Ceph GENES INVOLVED IN INFLAMMATORY BOWEL DISEASES AND THEIR USE
WO2001073022A1 (en) * 2000-03-29 2001-10-04 Kyowa Hakko Kogyo Co., Ltd. Proliferative glomerular nephritis-associated gene
US20030198953A1 (en) * 2000-03-30 2003-10-23 Spytek Kimberly A. Novel proteins and nucleic acids encoding same
EP1294899B3 (en) * 2000-03-31 2011-07-06 Millennium Pharmaceuticals, Inc. 16836, a human phospholipase c family member and uses thereof
WO2001072957A2 (en) * 2000-03-31 2001-10-04 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
EP1268817A1 (en) 2000-04-07 2003-01-02 MERCK PATENT GmbH Human pyruvate dehydrogenese phosphatase
AU2001257117A1 (en) 2000-04-18 2001-10-30 Tularik, Inc. Sitosterolemia susceptibility gene (ssg): compositions and methods of use
US20030119081A1 (en) * 2001-10-29 2003-06-26 Millennium Pharmaceuticals, Inc. 32235, a human aminotransferase family member and uses therefor
US20020019348A1 (en) * 2000-08-02 2002-02-14 Applera Corporation Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
JP2003530877A (en) * 2000-04-26 2003-10-21 ピーイー コーポレーション （エヌワイ） Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
JP2004511208A (en) * 2000-04-28 2004-04-15 インサイト・ゲノミックス・インコーポレイテッド RNA metabolism protein
US20030096312A1 (en) * 2000-05-02 2003-05-22 Claudia Wilm Novel natrium-calcium exchanger protein
US6808876B1 (en) 2000-05-02 2004-10-26 Immusol, Inc. Cellular regulators of infectious agents and methods of use
US7034135B2 (en) 2000-05-03 2006-04-25 Millennium Pharmaceuticals, Inc. Molecules of the NBS/LRR protein family and uses thereof
WO2001083753A2 (en) * 2000-05-03 2001-11-08 Millennium Pharmaceuticals, Inc. Molecules of the nbs/lrr protein family and uses thereof
CA2408828A1 (en) * 2000-05-12 2001-11-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Novel serine-threonine kinase-4
US20030050441A1 (en) * 2000-09-25 2003-03-13 Millennium Pharmaceuticals, Inc. 49938, a novel human phospholipid transporter and uses therefor
WO2001088135A2 (en) * 2000-05-15 2001-11-22 Curagen Corporation G-protein coupled receptor proteins and nucleic acids encoding same
AU2001274923A1 (en) * 2000-05-23 2001-12-03 Lexicon Genetics Incorporated Novel human thrombospondin-like proteins and polynucleotides encoding the same
EP1158049A1 (en) * 2000-05-26 2001-11-28 Aeomica, INC. Myosin-like gene expressed in human heart and muscle
GB2380197A (en) * 2000-05-26 2003-04-02 Aeomica Inc Myosin-like gene expressed in human heart and muscle
WO2001092524A2 (en) * 2000-05-26 2001-12-06 Aeomica, Inc. Myosin-like gene expressed in human heart and muscle
EP1700867A3 (en) * 2000-06-02 2006-09-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001096561A1 (en) * 2000-06-16 2001-12-20 Merck Patent Gmbh Hunc-2, human member of unc-protein family
EP1176200A3 (en) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
CN1281749C (en) 2000-06-26 2006-10-25 味之素株式会社 Polypeptides, use thereof and process for producing the same
CA2412256A1 (en) * 2000-06-27 2002-01-03 Curagen Corporation Polynucleotides and polypeptides encoded thereby
US20020039773A1 (en) * 2000-07-13 2002-04-04 Rosana Kapeller-Libermann 47885, a novel human ubiquitin-activating enzyme and uses therefor
WO2002006318A2 (en) * 2000-07-18 2002-01-24 Board Of Regents, The University Of Texas System Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
EP1174502A1 (en) * 2000-07-18 2002-01-23 Schering Corporation Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
CA2416732C (en) * 2000-08-02 2016-02-09 Brad St. Croix Endothelial cell expression patterns
DK1309690T3 (en) * 2000-08-18 2006-09-18 Merck Patent Gmbh MFQ-111, a human GTPase-like protein
AU2001285224A1 (en) * 2000-08-24 2002-03-04 Incyte Genomics, Inc. Kidney-specific protein
WO2002018420A2 (en) * 2000-08-28 2002-03-07 Lion Bioscience Ag Cofactors of the pregnane x receptor and methods of use
WO2002018582A2 (en) * 2000-08-31 2002-03-07 Millennium Pharmaceuticals, Inc. 62112, a novel human dehydrogenase and uses thereof
CA2460014A1 (en) * 2000-09-21 2002-03-28 The Regents Of The University Of California Spas-1 cancer antigen
US7358348B2 (en) 2000-09-22 2008-04-15 Kyowa Hakko Kogyo Co., Ltd. β-catenin nuclear localized protein
AU2001294684A1 (en) * 2000-09-29 2002-04-08 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
CA2423424A1 (en) * 2000-09-29 2002-04-04 Incyte Genomics, Inc. Secreted proteins
US20020150916A1 (en) * 2000-10-05 2002-10-17 Rachel Meyers 43716, a novel human G-protein and uses thereof
AU1153902A (en) 2000-10-06 2002-04-15 Univ Yale Nogo receptor homologs
NZ525443A (en) 2000-10-12 2006-04-28 Ferring Bv Dipeptidyl peptidase IV related genes
AU2002221676A1 (en) * 2000-10-16 2002-04-29 Bayer Aktiengesellschaft Regulation of human acyl-coa dehydrogenase
US20020119518A1 (en) * 2000-10-17 2002-08-29 Merkulov Gennady V. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001295778A1 (en) * 2000-10-20 2002-04-29 Inpharmatica Limited Novel cysteine proteases and uses thereof
JP2004512045A (en) * 2000-10-24 2004-04-22 アベンティス・ファーマ・ソシエテ・アノニム Nucleic acids that regulate the ABCA7 gene, molecules that modulate its activity, and therapeutic uses
FR2822165B1 (en) * 2000-10-24 2004-12-24 Aventis Pharma Sa NUCLEIC ACID REGULATING THE ABCA7 GENE, MOLECULES MODULATING ITS ACTIVITY AND THERAPEUTIC APPLICATIONS
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
EP1337544A4 (en) * 2000-10-30 2004-12-08 Bristol Myers Squibb Co Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
WO2002036781A2 (en) * 2000-10-31 2002-05-10 Bayer Aktiengesellschaft Regulation of human glutathione-s-transferase
WO2002048369A2 (en) * 2000-11-02 2002-06-20 Bristol-Myers Squibb Company Polynucleotide encoding a human potassium channel beta-subunit, k+mbeta1
AU2002225852A1 (en) * 2000-11-14 2002-05-27 Millenium Pharmaceuticals, Inc. "67118", "67067" and "62092", human proteins and methods of use thereof
EP1337559A2 (en) * 2000-11-17 2003-08-27 Bayer Ag Regulation of human nmda receptor
WO2002042457A1 (en) 2000-11-22 2002-05-30 Bristol-Myers Squibb Company Cloning and expression of human slap-2: a novel sh2/sh3 domain-containing human slap homologue having immune cell-specific expression
CA2324663A1 (en) * 2000-11-27 2002-05-27 The Hospital For Sick Children A novel adapter gene
WO2002044358A2 (en) * 2000-11-28 2002-06-06 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3
WO2002046402A2 (en) * 2000-12-05 2002-06-13 Bayer Aktiengesellschaft Regulation of human patched-like protein
WO2002081667A2 (en) * 2000-12-05 2002-10-17 Incyte Genomics, Inc. Ligases
EP1379879A2 (en) * 2000-12-08 2004-01-14 Oxford GlycoSciences (UK) Limited Diagnosis and treatment of alzheimer's disease
US20040082051A1 (en) * 2000-12-14 2004-04-29 Zhimin Zhu Regulation of human uridine kinase
CA2433740A1 (en) * 2001-01-09 2002-07-18 Keio University Human glioma antigen and process for preparing the same
US7122345B2 (en) 2001-01-09 2006-10-17 Curagen Corporation Nucleic acid encoding a NOVX13 polypeptide
WO2002055707A2 (en) * 2001-01-10 2002-07-18 Rigel Pharmaceuticals Inc Cloning of an inhibitor of antigen-receptor signaling by a retroviral-based functional screen
US6605710B2 (en) * 2001-01-11 2003-08-12 Board Of Trustees Of Michigan State University Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
US20020119523A1 (en) * 2001-01-17 2002-08-29 Millennium Pharmaceuticals, Inc. 67073, a human phospholipid transporter family member and uses therefor
JPWO2002057444A1 (en) * 2001-01-22 2004-05-20 近藤　科江 Human apoptosis-related gene and its product, human apoptosis-related protein
WO2002063006A2 (en) * 2001-02-06 2002-08-15 Incyte Genomics, Inc. Receptors and membrane-associated proteins
CA2438018A1 (en) * 2001-02-07 2002-08-15 Universiteit Maastricht Markers of unstable atherosclerotic plaques
WO2002064783A2 (en) * 2001-02-09 2002-08-22 Lion Bioscience Ag Novel cofactors of the estrogen receptor beta and methods of use
WO2002064762A2 (en) * 2001-02-12 2002-08-22 Bayer Aktiengesellschaft Isolated polynucleotides encoding putative tyrosine kinase
WO2002064777A2 (en) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
WO2002072138A1 (en) * 2001-03-08 2002-09-19 Hyseq, Inc. Methods and materials relating to fibulin-like polypeptides and polynucleotides
EP1373526A4 (en) * 2001-03-08 2006-01-25 Curagen Corp Therapeutic polypeptides, nucleic acids encoding same, and methodes of use
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
US6913904B2 (en) * 2001-03-27 2005-07-05 Applera Corporation Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
US20020168668A1 (en) * 2001-03-27 2002-11-14 Millennium Pharmaceuticals, Inc. 14691, a human glutamate receptor family member and uses therefor
AU2002258622A1 (en) * 2001-03-27 2002-10-08 Human Genome Sciences, Inc. Human secreted proteins
EP1390057A4 (en) * 2001-04-03 2005-10-12 Curagen Corp Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US20040062761A1 (en) 2001-04-10 2004-04-01 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
WO2002083706A1 (en) * 2001-04-16 2002-10-24 Lexicon Genetics Incorporated Nucleic acid encoding a human adenylosuccinate synthetase
AU2002254615A1 (en) * 2001-04-17 2002-10-28 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
EP1383533A4 (en) * 2001-04-23 2006-11-02 Curagen Corp Proteins and nucleic acids encoding same
EP1399460A4 (en) * 2001-04-27 2005-04-13 Sunnybrook & Women S College H Breast cancer-associated genes and uses thereof
AUPR470101A0 (en) * 2001-05-02 2001-05-24 Murdoch Childrens Research Institute, The A molecular marker
US20030017159A1 (en) * 2001-05-02 2003-01-23 Jerome Ritz Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
JP4231778B2 (en) * 2001-05-29 2009-03-04 株式会社ヒューマンセルシステムズ Testicular carnitine transporter and its gene
EP1404807A4 (en) * 2001-06-06 2005-03-23 Human Genome Sciences 20 human secreted proteins
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
EG26529A (en) * 2001-06-11 2014-01-27 مونسانتو تكنولوجى ل ل سى Cotton event mon 15985 and compositions and methods for detection thereof
US7488587B2 (en) * 2001-06-19 2009-02-10 The J. David Gladstone Institutes Histone deacetylase and methods of use thereof
EP1402031A2 (en) 2001-06-21 2004-03-31 Isis Innovation Limited Atopy
AT410945B (en) * 2001-06-27 2003-08-25 Burkhard Dr Jansen Diagnosis of multiple sclerosis or tumors, by detecting absence of wild-type stem cell factor-apoptosis response gene, or the derived protein, also new nucleic acids
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
BR0210835A (en) * 2001-07-05 2004-07-13 Wyeth Corp Agrecanase Molecules
JP4702819B2 (en) 2001-08-01 2011-06-15 生化学工業株式会社 Chondroitin synthase
GB2399086A (en) * 2001-08-02 2004-09-08 Aeomica Inc Human zinc finger containing gene MDZ4
WO2003102029A1 (en) * 2001-08-15 2003-12-11 Endocube Sas Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
WO2003027279A1 (en) * 2001-09-25 2003-04-03 Sony Corporation p300 HISTONE ACETYLASE INHIBITOR
WO2003031627A1 (en) * 2001-09-28 2003-04-17 Hokkaido Technology Licensing Office Co., Ltd. Platelet-origin polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
DE10148037A1 (en) * 2001-09-28 2003-04-17 Aventis Behring Gmbh Use of the protease activating the blood coagulation factor VII for the prophylaxis and therapy of vaso-proliferative diseases
US7138370B2 (en) * 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
EP1444255A2 (en) * 2001-10-26 2004-08-11 Incyte Genomics, Inc. Vesicle-associated proteins
WO2003037930A1 (en) * 2001-10-29 2003-05-08 Kazusa Dna Research Institute Foundation Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same
GB2381526A (en) * 2001-11-03 2003-05-07 Sequenom Inc Detection of predisposition to osteoporosis
ATE553120T1 (en) 2001-11-16 2012-04-15 Eisai R&D Man Co Ltd PROTEINS OF THE JEAP FAMILY, COMPONENTS OF THE TIGHT CONNECTIONS OF THE EXOCRINE GLANDS
ES2462740T3 (en) 2001-11-26 2014-05-26 Laboratoire Biodim Protein-protein interactions in human immunodeficiency virus
AUPR913901A0 (en) * 2001-11-27 2001-12-20 Children's Medical Research Institute Muscle transcription factors
AU2002365894A1 (en) 2001-11-30 2003-06-17 Children's Hospital Medical Center Antibodies to magmas and uses thereof
ATE451387T1 (en) * 2001-12-18 2009-12-15 Endocube Sas NEW CELL DEATH-ASSOCIATED PROTEINS FROM THE THAP FAMILY AND PAR4-RELATED SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF APOPTOSIS
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
WO2003064654A1 (en) * 2002-02-01 2003-08-07 Bayer Healthcare Ag Human serine/threonine protein kinase
JP2003252801A (en) * 2002-02-27 2003-09-10 Japan Science & Technology Corp Method for using pituitary-specific gene
AU2003218208A1 (en) 2002-03-19 2003-10-08 Children's Medical Center Corporation Methods for diagnosis and prognosis of cancer
AU2003220274A1 (en) * 2002-03-22 2003-10-13 Munin Corporation Cloning and characterization of g+c-rich promoter binding protein
US7473526B2 (en) * 2002-03-29 2009-01-06 Veridex, Llc Breast cancer prognostic portfolio
WO2003102164A2 (en) * 2002-05-30 2003-12-11 Avalon Pharmaceuticals, Inc. Cancer-linked gene as target for chemotherapy
AU2003260618A1 (en) * 2002-06-24 2004-01-06 Exonhit Therapeutics Sa Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
GB0215406D0 (en) * 2002-07-03 2002-08-14 Inpharmatica Ltd Protein
AU2003249013A1 (en) 2002-07-09 2004-01-23 Bristol-Myers Squibb Company Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
US7122358B2 (en) 2002-07-09 2006-10-17 Bristol-Myers Squibb Company Testis-specific tubulin tyrosine-ligase-like protein, BGS42
KR101083852B1 (en) * 2002-07-25 2011-11-15 소니 주식회사 A gene transcription regulator and a screening method for a compound inhibiting histone deacetylase
WO2004012817A2 (en) * 2002-07-31 2004-02-12 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
DE10309368A1 (en) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmaceutical preparation with RNA as a cofactor of hemostasis
EP1534833A4 (en) * 2002-08-09 2006-06-07 Melbourne Health Mammalian grainyhead transcription factors
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
US20060182755A1 (en) * 2002-09-11 2006-08-17 Genentech, Inc. Novel composition and methods for the treatment of psoriasis
WO2004031731A2 (en) * 2002-10-02 2004-04-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for controlling proliferation of cells
AU2003291990A1 (en) * 2002-10-25 2004-05-13 Technische Universitaet Muenchen Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof
EP1578372A4 (en) * 2002-11-15 2007-10-17 Univ Arkansas Ca125 gene and its use for diagnostic and therapeutic interventions
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
AU2003297696A1 (en) * 2002-12-05 2004-06-30 Diadexus, Inc. Compositions,splice variants and methods relating to breast specific genes and proteins
WO2004063223A2 (en) * 2002-12-27 2004-07-29 Applied Research Systems Ars Holding N.V. Notch-like polypeptides
US7326768B2 (en) 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
UA87106C2 (en) 2003-03-19 2009-06-25 Байоджен Айдек Ма Інк. Nogo receptor binding protein
JP4643450B2 (en) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス Cancer high expression gene
ATE371724T1 (en) * 2003-09-05 2007-09-15 Cellzome Ag TREATMENT OF NEURODEGENERATIVE DISEASES
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
EP1734998A2 (en) 2004-04-14 2006-12-27 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
CA2619256A1 (en) * 2004-09-24 2006-03-30 Mount Sinai Hospital Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
GB0426960D0 (en) 2004-12-08 2005-01-12 Ares Trading Sa TGR-3 like protein receptor
JP5517450B2 (en) * 2005-03-10 2014-06-11 バイオンテック アーゲー Dimeric or multimeric microproteins
US7893032B2 (en) 2005-07-07 2011-02-22 Yale University NgR variants and compositions thereof for suppressing axonal growth inhibition
SI1904104T1 (en) 2005-07-08 2013-12-31 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
US7811787B2 (en) 2006-04-25 2010-10-12 Bristol-Myers Squibb Company Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
JP2011527572A (en) 2008-07-09 2011-11-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド Composition comprising a LINGO antibody or fragment
DE102008045696A1 (en) 2008-09-04 2010-03-11 Drk Blutspendedienst West Ggmbh Granulocyte HNA-3a / b antigen
EP3124494B1 (en) * 2008-12-09 2019-06-19 Dana-Farber Cancer Institute, Inc. Methods and compositions for specific modulation of mcl-1
US8444983B2 (en) 2009-03-23 2013-05-21 Quark Pharmaceuticals, Inc. Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
JP5383905B2 (en) 2009-05-08 2014-01-08 ジェネンテック， インコーポレイテッド Humanized anti-EGFL7 antibody and method of use thereof
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
MX2014013950A (en) 2012-05-14 2015-02-17 Biogen Idec Inc Lingo-2 antagonists for treatment of conditions involving motor neurons.
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
KR20240033145A (en) 2012-11-13 2024-03-12 비온테크 에스이 Agents for treatment of claudin expressing cancer diseases
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer
EP3077411A1 (en) * 2013-12-03 2016-10-12 Institut National de la Santé et de la Recherche Médicale (INSERM) Mafb mutants and uses thereof
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
CN112190710B (en) * 2020-10-28 2021-07-30 江苏省人民医院（南京医科大学第一附属医院） Application of lipid-derived polypeptide in preparation of metastatic breast cancer targeted drug
WO2022212928A1 (en) * 2021-04-02 2022-10-06 The Regents Of The University Of California Modified viruses and viral particles, methods of making, and uses thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783485B2 (en) * 1999-11-10 2005-11-03 Lexicon Pharmaceuticals, Inc. Human atpase proteins and polynucleotides encoding the same
AU784349B2 (en) * 2000-01-12 2006-03-16 Yale University Nogo receptor-mediated blockade of axonal growth
AU784349C (en) * 2000-01-12 2006-09-28 Yale University Nogo receptor-mediated blockade of axonal growth
AU2001249421B2 (en) * 2000-03-24 2006-09-07 Genetics Institute, Llc A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
AU2001262734B2 (en) * 2000-06-14 2004-09-30 Sankyo Company, Limited Ceramide kinase and DNA encoding the same

Also Published As

Publication number Publication date
WO2000058473A2 (en) 2000-10-05
JP2004507202A (en) 2004-03-11
WO2000058473A3 (en) 2001-01-25
CA2383592A1 (en) 2000-10-05
EP1165784A2 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
AU3774500A (en) Nucleic acids including open reading frames encoding polypeptides; "orfx"
AU1220001A (en) Novel proteins and polynucleotides encoding them
WO1999046281A8 (en) Novel polypeptides and nucleic acids encoding the same
AU6311798A (en) MRI contrast media recognizing microenvironmental changes
AU1675900A (en) Complementary dna's encoding proteins with signal peptides
AU5372399A (en) Dna encoding a human inhibitor-of-apoptosis protein; hiap3
AU4930399A (en) Novel Polypeptide
AU1891301A (en) Novel polypeptide and dna thereof
AU2071799A (en) Placental protein 13
AU1881200A (en) Novel proteins
HK1048495A1 (en) Dna encoding prost 07 polypeptide
AU4778600A (en) Novel polypeptide
AU3452700A (en) Antibodies to placental protein 13
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
AU4306401A (en) Dna encoding a novel prost-ets polypeptide
AU1486801A (en) Novel growth factor polypeptides and nucleic acids encoding same
AU1458600A (en) Transmembrane 4 proteins
AU1540701A (en) Novel protein
AU6181500A (en) Gene encoding novel tsp1-like protein
AU5840300A (en) Glutx polypeptide family and nucleic acids encoding same
AU2057800A (en) Novel hyaluronan-binding proteins and encoding genes
AU2002500A (en) Novel protein
AU7304600A (en) Novel protein
AU4765599A (en) Lafora's disease gene
AU2109200A (en) Polypeptide